Answers are grounded in this paper and cite their sources.
Heat stress significantly hinders broiler output by compromising gut integrity, oxidative balance, and immune function.This study evaluated nano-encapsulated phytogenic compounds (NEP) as a nutritional strategy to alleviate heat stress.Three hundred sixty males of Cobb500 broilers were allocated to a 2×3 factorial design with two ambient temperatures and three dietary treatments (6 replicate pens × 10 birds).Birds received a basal diet supplemented with a conventional phytogenic extract (CPE, 500mg/kg), NEP (250mg/kg), or no supplementation (CON).The phytogenic blend contained curcumin (40%), resveratrol (30%), and quercetin (30%) and the NEP consisted of this blend encapsulated in PEGylated liposomes (80-120nM particle size, >85% encapsulation efficiency).From 22-42 days, birds were exposed to a cyclic heat stress treatment (HS; 38°C, 8h/day) or maintained under thermoneutral conditions (TN; 24°C).In CON birds, HS reduced body weight gain (BWG) and feed intake by 24 and 11%, respectively, and increased the feed-togain (F:G) ratio by 16% (P<0.05).Compared with HS-CON, NEP increased BWG (+21%) and improved the F:G ratio (-13%).Under HS, NEP reduced serum interleukin-6 (IL-6; -55%), hepatic malondialdehyde (-50%) and jejunal NF-κB mRNA expression (-2.5-fold), and increased serum IL-10 (+89%), IgA (+114%), IgG (+47%), hepatic superoxide dismutase activity (+46%) and glutathione peroxidase (+90%) activities, and jejunal occludin (+2.4-fold), claudin-1 (+2.3-fold) and Nrf2 (+2.2-fold) mRNA expression (P<0.05).NEP also increased the villus height/crypt depth ratio (+2-fold) and cecal Lactobacillus counts (+1.43 log10 copies/g) and reduced cecal Escherichia coli counts (-1.20 log10 copies/g).In direct comparisons under HS, NEP produced greater responses than CPE for most variables.These findings indicate that NEP, supplemented at half the CPE inclusion rate, attenuated several heat-stress-induced impairments in broilers.Because each formulation was tested at a single, non-equivalent inclusion level without a carrieronly control and bioavailability was not measured, dose-response, carrier-controlled and pharmacokinetic studies are needed to confirm a dose-sparing effect and the underlying mechanisms.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: